Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
复制标题
血浆巨噬细胞迁移抑制因子和 CCL3 作为区分鼻咽癌患者与 Epstein-Barr 病毒衣壳抗原特异性 IgA 阳性的高危个体的潜在生物标志物。
DOI：
10.4143/crt.2018.070
复制
发表时间：
2018
影响因子：
4.6
通讯作者：
Liu Wan-Li
中科院分区：
文献类型：
--
作者：
Xue Ning;Lin Jian-Hua;Xing Shan;Liu Dan;Li Shi-Bing;Lai Yan-Zhen;Wang Xue-Ping;Mao Min-Jie;Zhong Qian;Zeng Mu-Sheng;Liu Wan-Li
